Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hua Medicine

HUMDF
Current price
0.15 USD 0 USD (0.00%)
Last closed 1.66 HKD
ISIN KYG4644K1022
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange HK
Capitalization 1 776 005 968 HKD
Yield for 12 month +1.18 %
1Y
3Y
5Y
10Y
15Y
HUMDF
21.11.2021 - 28.11.2021

Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D and DKD. The company also offers Dorzagliatin in combination with GLP1RA for T2D and obesity; in combination with insulin to treat Type 1 Diabetes; second generation glucokinase (GK) inhibitor for metabolic disease; mGLUR5 negative allosteric modulator (NAM) for PD-LID and drug addiction; and GK NAM for metabolic disease. The company was incorporated in 2011 and is based in Shanghai, China. Address: Building 2, Lane 36, Shanghai, China, 201203

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

27.91 HKD

P/E ratio

Dividend Yield

Current Year

+83 900 459 HKD

Last Year

+19 273 775 HKD

Current Quarter

Last Quarter

Current Year

+40 930 628 HKD

Last Year

+8 420 712 HKD

Current Quarter

Last Quarter

Key Figures HUMDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -382 978 384 HKD
Operating Margin TTM -189.19 %
PE Ratio
Return On Assets TTM -17.81 %
PEG Ratio
Return On Equity TTM -300.57 %
Wall Street Target Price 27.91 HKD
Revenue TTM 108 952 637 HKD
Book Value -0.034 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 46 %
Dividend Yield
Gross Profit TTM 7 689 751 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin -241.76 %

Dividend Analytics HUMDF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HUMDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation HUMDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.4793
Price Sales TTM 16.3007
Enterprise Value EBITDA -11.5504
Price Book MRQ 10.5004

Financials HUMDF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HUMDF

For 52 weeks

1.03 HKD 2.65 HKD
50 Day MA 1.34 HKD
Shares Short Prior Month
200 Day MA 1.49 HKD
Short Ratio
Shares Short
Short Percent